TAMPA, Fla., Oct. 10, 2023 /PRNewswire/ -- ClinIntell, the healthcare industry's leading severity-reporting data analytics company, announces the launch of CDI 2.0, a next-generation and progressive severity-reporting and clinical documentation improvement (CDI) approach. CDI 2.0 enhances traditional CDI models by utilizing sophisticated insights through the analysis of inpatient claims level data.

佛罗里达州坦帕市，2023年10月10日/PRNewswire/-医疗行业领先的严重性报告数据分析公司ClinIntell宣布推出CDI 2.0，这是一种新一代逐步严重性报告和临床文件改进（CDI））方法。CDI 2.0通过分析住院患者索赔水平数据利用复杂的见解来增强传统的CDI模型。

This model ushers in a new era of proactive, data-driven, and provider-focused severity documentation improvement strategies..

该模型开创了积极，数据驱动和以提供商为中心的严重性文档改进策略的新时代。。

Continue Reading

继续阅读

Traditional CDI models (CDI 1.0) rely heavily on chart reviews and insights derived from benchmarking claims data. CDI 2.0 enables a proactive provider-focused addition, with insights into severity documentation vulnerabilities derived from sophisticated analytics applied to your hospital's unique and ever-changing inpatient population..

传统的CDI模型（CDI 1.0）在很大程度上依赖于图表审查和对索赔数据进行基准测试得出的见解。CDI 2.0可实现主动的以供应商为中心的补充，深入了解应用于医院独特且不断变化的住院人群的复杂分析所带来的严重性文档漏洞。。

ClinIntell, the healthcare industry's leading severity-reporting data analytics company, announces the launch of CDI 2.0

医疗行业领先的严重性报告数据分析公司ClinIntell宣布CDI 2.0推出

Tweet this

推特这个

ClinIntell's revolutionary population-based approach combines advanced analytics with dynamic visualization tools, improvement strategies, and a provider-specific training and performance-monitoring mobile app that achieves long-term sustainable results.

ClinIntell革命性的基于人群的方法将先进的分析与动态可视化工具，改进策略以及特定于提供商的培训和性能监控移动应用程序相结合，从而实现长期可持续的结果。

'On their own, traditional CDI approaches simply cannot keep pace with the growing complexities and demands of the current post-COVID healthcare environment, which includes the constant pressure to do more with less,' says Terrance Govender, MD, ClinIntell's Vice President of Medical Affairs at Becker's Annual HITRCM in October 2023.

ClinIntell副总裁Terrance Govender博士说：“就其自身而言，传统的CDI方法根本无法跟上当前新型冠状病毒肺炎后医疗环境日益增长的复杂性和需求，其中包括持续不断的压力，少做更多事情。”贝克尔年度HITRCM医疗事务部于2023年10月发布。

'We have pioneered a population and provider-focused approach to optimizing your organization's severity reporting data with CDI 2.0. Healthcare executives now have a proactive provider-focused option to augment current efforts, driving scalable and sustainable severity documentation improvements.'  Core differentiators and features that facilitate CDI 2.0:.

“我们率先采用以人口和供应商为中心的方法，使用CDI 2.0优化您组织的严重性报告数据。医疗保健高管现在拥有以供应商为中心的积极选择，以增强当前的工作，推动可扩展和可持续的严重性文档改进促进CDI 2.0的核心差异化器和功能：。

Empowering leadership with a system to optimize provider-level data for a 'top-down' approach to documentation improvement.

通过系统授权领导层优化提供商级数据，以“自上而下”的方式改进文档。

Fostering provider accountability through personalized tracking and reports.

通过个性化跟踪和报告促进供应商问责制。

Providing insights that promote collaboration between clinicians across specialties.

提供促进临床医生跨专业合作的见解。

Offering actionable insights and a Targeted List of Conditions to drive efficient, impactful, and meaningful documentation improvement strategies.

提供可行的见解和有针对性的条件列表，以推动有效，有影响力和有意义的文档改进策略。

Tracking short- and long-term documentation performance gaps at the health system, facility, and provider levels.

跟踪卫生系统，设施和提供者级别的短期和长期文档绩效差距。

Pushing customized and transparent reports to clinical leadership, with insights into provider and peer documentation performance across targeted conditions.

将定制和透明的报告推向临床领导层，深入了解目标条件下的提供商和同行文档绩效。

Empowering individual providers with ongoing performance monitoring data and severity documentation training, including clinically relevant tips on targeted lists of conditions.

为个体提供者提供持续的绩效监测数据和严重性文件培训，包括针对目标条件列表的临床相关提示。

Healthcare executives lack the analytical data insights to enable a progressive, more efficient top-down provider-focused approach.ClinIntell's predictive analytics enables the industry to break through the diminishing marginal returns of CDI 1.0 and jump the curve to CDI 2.0, promoting proactive optimization of documentation initiatives.

医疗保健高管缺乏分析数据见解，无法实现逐步，更有效的自上而下的以供应商为中心的方法。ClinIntell的预测分析使该行业能够突破CDI 1.0的边际收益递减，并将曲线跳至CDI 2.0，从而促进文档计划的主动优化。

This pioneering approach results in greater physician engagement for sustainable improvements in accurate patient severity reporting.The next era of CDI starts now. About ClinIntellClinIntell is a healthcare technology company that has pioneered patient population severity reporting through the analysis of claims data.

这种开创性的方法导致更多的医生参与，以可持续改进准确的患者严重程度报告。CDI的下一个时代现在开始了。关于ClinIntellClinIntell是一家医疗保健技术公司，通过对索赔数据的分析开创了患者人群严重程度报告的先河。

ClinIntell's patient population severity reporting analytics and metrics enable acute care organizations to optimize reimbursement and risk adjustment reporting via a lean, provider-focused approach. Our approach, uniquely named CDI 2.0, removes the industry's reliance on benchmarking, which can be misleading, to assess severity reporting performance and identify opportunities to improve.To learn more about CDI 2.0's breakthrough predictive capabilities firsthand, visit clinintell.com or book a demo to see your hospital's unique patient population mix using publicly available Medicare data and our proprietary algorithms.Contact: Xia Johnson, [email protected]SOURCE ClinIntell.

ClinIntell的患者人群严重程度报告分析和指标使急症护理机构能够通过精益，以供应商为中心的方法优化报销和风险调整报告。我们的方法名为CDI 2.0，消除了业界对基准测试的依赖，这可能会产生误导，以评估严重性报告绩效并确定改进的机会。要直接了解有关CDI 2.0突破性预测功能的更多信息，请访问clinintell.com或预订演示，使用公开的Medicare数据和我们专有的算法查看您医院独特的患者人群组合。联系方式：Xia Johnson，[电子邮件保护]来源ClinIntell。